title: The effect of PGE administration on the activity of oxidative system in erythrocytes and platelets during ischemia reperfusion injury and on postoperative renal function in patients undergoing open abdominal aortic aneurysm reconstruction.
abstract: Postoperative decline of renal function remains a common and unpredictable complication after abdominal aortic aneurysm (AAA) reconstruction. The oxidative stress that occurs during perioperative ischemia/reperfusion injury (I/R) may contribute to the development of this complication. In this study, the influence of intraoperative prostaglandin E (alprostadil) administration on erythrocyte and platelet antioxidants as well as postoperative kidney function modulation were verified. AAA patients were randomly divided into control and study/alprostadil groups. Blood samples were collected directly before aortic clamping and 5 min after aortic declamping. Superoxide dismutase, catalase, glutathione, glutathione peroxidase (GPx), and glutathione transferase (GST) were measured using spectrophotometry. During I/R, the activity of catalase (57.14+/-30.65 vs 128.35+/-91.94 U/mg protein; P < 0.009), GPx (0.21+/-0.18 vs 0.35+/-0.21 mU/g protein; P = 0.028), and GST (217.49+/-101.39 vs 310.66+/-88.86 mU/g protein; P = 0.0006) significantly increased in the control group. GST activity before the aortic clamping was significantly lower in the study/alprostadil group (2.84+/-2.28 vs 3.48+/-2.30 U/g Hb; P = 0.05). The activity of the selected antioxidants proved to be of a diagnostic value for predicting postoperative decline in renal function. In conclusion, during I/R after AAA reconstruction, activation of various erythrocyte and platelet antioxidants occurs. Perioperative administration of alprostadil is associated with disruption of this activation.
authors.affiliation: Department of Medical Analytics, Pomeranian Medical University, Szczecin, Poland. drannab@wp.pl
authors.forename: W
authors.initials: W
authors.lastname: Blogowski
authors.forename: B
authors.initials: B
authors.lastname: Dolegowska
authors.forename: E
authors.initials: E
authors.lastname: Pikula
authors.forename: P
authors.initials: P
authors.lastname: Gutowski
authors.forename: T
authors.initials: T
authors.lastname: Starzynska
mesh_terms: D000368:Aged; D000527:Alprostadil / Q000008:administration & dosage*; D000975:Antioxidants / Q000378:metabolism; D017544:Aortic Aneurysm, Abdominal / Q000378:metabolism / Q000473:pathology / Q000601:surgery*; D001792:Blood Platelets / Q000378:metabolism*; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D007668:Kidney / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D007674:Kidney Diseases / Q000097:blood* / Q000209:etiology / Q000473:pathology; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000097:blood; D015427:Reperfusion Injury / Q000097:blood* / Q000209:etiology / Q000473:pathology; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D000975:Antioxidants; D014665:Vasodilator Agents; D010088:Oxidoreductases; D000527:Alprostadil